Elidel pimecrolimus dermatology data

Data from the 26-week, double-blind, vehicle-controlled (PEP study4) trial in 543 adult patients showed that the mean number of flare-ups was reduced to 0.97 with Elidel vs. 1.39 for control. Median t...